Entered Into Open Market Sale Agreement With Jefferies On May 6 Relating To Sale Of Ordinary Shares
06/05/2021 22:37
May 6 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS PLC - ENTERED INTO OPEN MARKET SALE
AGREEMENT WITH JEFFERIES ON MAY 6 RELATING TO SALE OF ORDINARY
SHARES
* NABRIVA THERAPEUTICS PLC - MAY OFFER, SELL ORDINARY SHARES
FOR
AGGREGATE GROSS SALE PROCEEDS OF UP TO $50 MILLION FROM TIME TO
TIME
Source text: https://bit.ly/3o5KKCB
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update